Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:BBNX NASDAQ:EMBC NASDAQ:SIBN NASDAQ:SKIN On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeBBNXBeta Bionics$15.81-3.7%$15.81$8.89▼$24.50$713.78MN/A559,987 shs562,948 shsEMBCEmbecta$9.92+1.3%$10.22$9.20▼$21.48$572.15M1.08540,605 shs560,567 shsSIBNSiBone$16.00-10.6%$17.84$11.70▼$20.05$762.80M0.91325,978 shs1.79 million shsSKINBeauty Health$1.65+3.1%$1.77$0.78▼$2.38$201.59M1.2665,442 shs264,849 shsTen Starter Stocks For Beginners to Buy NowJust getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceBBNXBeta Bionics-3.71%+7.84%+16.94%+10.02%+1,580,999,900.00%EMBCEmbecta+1.33%-7.72%-3.88%-20.38%-29.84%SIBNSiBone-10.61%-10.21%-13.33%-8.41%+13.96%SKINBeauty Health+3.12%-2.37%-31.82%+16.20%+22.22%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationBBNXBeta Bionics2.7173 of 5 stars4.40.00.00.03.00.80.0EMBCEmbecta4.6875 of 5 stars3.23.03.30.03.03.33.8SIBNSiBone4.0507 of 5 stars3.53.00.03.31.92.50.6SKINBeauty Health1.6415 of 5 stars2.80.00.00.03.23.30.0Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceBBNXBeta Bionics 2.75Moderate Buy$22.5642.67% UpsideEMBCEmbecta 2.33Hold$19.0091.53% UpsideSIBNSiBone 3.00Buy$23.6747.92% UpsideSKINBeauty Health 1.67Reduce$2.0826.26% UpsideCurrent Analyst Ratings BreakdownLatest SKIN, SIBN, BBNX, and EMBC Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails8/5/2025SIBNSiBoneCantor FitzgeraldSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingOverweight ➝ Overweight$25.008/1/2025SKINBeauty HealthStifel NicolausSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetHold ➝ Hold$3.00 ➝ $4.007/30/2025BBNXBeta BionicsTruist FinancialSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetBuy ➝ Buy$18.00 ➝ $21.007/30/2025BBNXBeta BionicsRobert W. BairdSubscribe to MarketBeat All Access for the recommendation accuracy ratingSet Price TargetNeutral ➝ Neutral$15.00 ➝ $17.007/16/2025EMBCEmbectaMizuhoSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetNeutral ➝ Neutral$13.00 ➝ $12.006/16/2025BBNXBeta BionicsTruist FinancialSubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageBuy$26.006/12/2025BBNXBeta BionicsLake Street CapitalSubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageBuy ➝ Buy$30.005/30/2025BBNXBeta BionicsThe Goldman Sachs GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageNeutral$16.005/30/2025BBNXBeta BionicsWolfe ResearchSubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageOutperform$20.005/23/2025EMBCEmbectaBTIG ResearchSubscribe to MarketBeat All Access for the recommendation accuracy ratingSet Price TargetBuy ➝ Buy$25.005/23/2025EMBCEmbectaMizuhoSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetNeutral ➝ Neutral$15.00 ➝ $13.00(Data available from 8/6/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookBBNXBeta Bionics$65.12M10.55N/AN/A$6.94 per share2.28EMBCEmbecta$1.12B0.52$3.39 per share2.93($12.80) per share-0.78SIBNSiBone$167.18M4.08N/AN/A$3.98 per share4.02SKINBeauty Health$334.30M0.62$0.07 per share25.30$0.41 per share4.02Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateBBNXBeta Bionics-$54.76MN/A0.00∞N/AN/AN/AN/AN/AEMBCEmbecta$78.30M$0.9011.023.230.634.89%-19.67%12.27%8/8/2025 (Estimated)SIBNSiBone-$30.91M-$0.64N/AN/AN/A-12.83%-14.28%-10.41%N/ASKINBeauty Health-$29.10M-$0.41N/AN/AN/A-11.94%-67.91%-5.56%8/7/2025 (Estimated)Latest SKIN, SIBN, BBNX, and EMBC EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/8/2025Q3 2025EMBCEmbecta$0.7720N/AN/AN/A$278.15 millionN/A8/7/2025Q2 2025SKINBeauty Health-$0.06N/AN/AN/A$74.67 millionN/A8/4/2025Q2 2025SIBNSiBone-$0.19-$0.14+$0.05-$0.14$48.12 million$48.63 million7/29/2025Q2 2025BBNXBeta Bionics-$0.51-$0.39+$0.12-$0.39$19.73 million$23.24 million5/9/2025Q2 2025EMBCEmbecta$0.66$0.70+$0.04$0.40$261.77 million$259.00 million5/8/2025Q1 2025SKINBeauty Health-$0.13-$0.08+$0.05-$0.08$63.88 million$69.60 million5/6/2025Q1 2025BBNXBeta Bionics-$0.51-$0.52-$0.01-$0.93N/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthBBNXBeta BionicsN/AN/AN/AN/AN/AEMBCEmbecta$0.606.05%N/A66.67%N/ASIBNSiBoneN/AN/AN/AN/AN/ASKINBeauty HealthN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioBBNXBeta BionicsN/A14.6813.79EMBCEmbectaN/A2.481.83SIBNSiBone0.218.537.26SKINBeauty Health12.017.476.43Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipBBNXBeta BionicsN/AEMBCEmbecta93.83%SIBNSiBone98.11%SKINBeauty Health93.26%Insider OwnershipCompanyInsider OwnershipBBNXBeta BionicsN/AEMBCEmbecta0.42%SIBNSiBone3.90%SKINBeauty Health41.00%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableBBNXBeta Bionics29443.47 millionN/AN/AEMBCEmbecta2,10058.44 million58.20 millionOptionableSIBNSiBone35042.62 million40.95 millionOptionableSKINBeauty Health1,030125.99 million74.34 millionOptionableSKIN, SIBN, BBNX, and EMBC HeadlinesRecent News About These CompaniesHere’s how to create radiant skin from the inside out3 hours ago | prestigeonline.comPBeauty and skincare lovers will adore this 24-hour coverage skin tintAugust 5 at 7:58 PM | rsvplive.ieRThe Key to Glowing Skin? It Might Just Be MatchaAugust 5 at 7:58 PM | msn.comMartha Stewart Is Finally Launching a Skin Care BrandAugust 5 at 7:58 PM | msn.comAfter Five Years in Development, Martha Stewart Is Launching Her Own Skin Care Line Elm BiosciencesAugust 4 at 10:18 AM | msn.comAt 84, Martha Stewart Launches Her First Skin-Care BrandAugust 4 at 10:18 AM | msn.comHow to take care of the skin of Ha Ji-won → Breaking down Fuji Mina Don Quixote...The first episode of 'Review It' will air on the 6thAugust 3 at 12:17 AM | msn.comBest Vitamins for Healthy Hair, Skin and Nails in 2025August 3 at 7:17 PM | yahoo.comStifel Nicolaus Boosts Beauty Health (NASDAQ:SKIN) Price Target to $4.00August 3 at 3:35 AM | americanbankingnews.comChinese beauty secrets that are waiting to be unravelledAugust 3 at 2:54 AM | msn.comHow lymphatic drainage massages can benefit your overall healthAugust 2, 2025 | msn.com6 Skin-Care Mistakes That Are Making Your Dark Spots WorseAugust 2, 2025 | self.comSStifel Nicolaus Issues Positive Forecast for Beauty Health (NASDAQ:SKIN) Stock PriceAugust 2, 2025 | marketbeat.com6 Skin Care Mistakes That Are Making Your Dark Spots WorseAugust 1, 2025 | msn.comYes, Lack of Sleep Is Ruining Your SkinAugust 1, 2025 | msn.comMonsoon skin problems and quick tips that helpAugust 1, 2025 | msn.comMonsoon Care: Want glowing skin in the rainy season? Adopt this viral beauty trend of blue skin care..August 1, 2025 | msn.comDIY Beauty Gone Wrong: Common Mistakes to Avoid with Home RemediesAugust 1, 2025 | msn.comBeauty Health (SKIN) Expected to Announce Quarterly Earnings on ThursdayAugust 1, 2025 | marketbeat.comThis Is How The Beauty Market Impacts Black Founders’ Mental HealthJuly 31, 2025 | essence.comESkin Care: Girls often make these 4 mistakes in the gym, it can cause great damage to the skin..July 31, 2025 | msn.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeSKIN, SIBN, BBNX, and EMBC Company DescriptionsBeta Bionics NASDAQ:BBNX$15.81 -0.61 (-3.71%) As of 08/5/2025 04:00 PM EasternBeta Bionics, Inc. is a commercial-stage medical device company. It engages in the design, development, and commercialization of solutions for insulin-requiring people with diabetes. The company was founded by Edward R. Damiano on October 21, 2015 and is headquartered in Irvine, CA.Embecta NASDAQ:EMBC$9.92 +0.13 (+1.33%) Closing price 08/5/2025 04:00 PM EasternExtended Trading$9.83 -0.09 (-0.91%) As of 08/5/2025 04:20 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety injection devices, as well as digital applications to assist people with managing patient's diabetes. The company primarily sells its products to wholesalers and distributors in the United States and internationally. Embecta Corp. was founded in 1924 and is headquartered in Parsippany, New Jersey.SiBone NASDAQ:SIBN$16.00 -1.90 (-10.61%) Closing price 08/5/2025 04:00 PM EasternExtended Trading$16.00 0.00 (0.00%) As of 08/5/2025 05:18 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.SI-BONE, Inc., a medical device company, that operate to solve musculoskeletal disorders of the sacropelvic anatomy in the United States and internationally. It offers proprietary minimally invasive surgical implant system to address sacroiliac joint dysfunction and fusion, adult deformity and degeneration, and pelvic trauma; and implantable bone products. The company also provides iFuse-3D, a titanium implant that combines the triangular cross-section of the iFuse implant with the proprietary 3D-printed porous surface and fenestrated design; iFuse-TORQ, a set of 3D-printed threaded implants designed to treat pelvic trauma; and iFuse Bedrock Granite implant provides sacroiliac fusion and sacropelvic fixation as a foundational element for segmental spinal fusion. It markets its products primarily with a direct sales force, as well as through agents and resellers. SI-BONE, Inc. was incorporated in 2008 and is headquartered in Santa Clara, California.Beauty Health NASDAQ:SKIN$1.65 +0.05 (+3.13%) Closing price 08/5/2025 04:00 PM EasternExtended Trading$1.62 -0.03 (-1.76%) As of 08/5/2025 07:31 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.The Beauty Health Company designs, develops, manufactures, markets, and sells aesthetic technologies and products worldwide. The company's flagship product includes HydraFacial that enhance the skin to cleanse, extract, and hydrate the skin with proprietary solutions and serums. Its products also comprise Syndeo, a Delivery System designs to connects providers to the consumer's preferences to create a more personalized experience; consumables, such as single-use tips, solutions, and serums used to provide a hydrafacial treatment; SkinStylus SteriLock Microsystem, a microneedling device used for the treatment of enhancing appearance of surgical or traumatic hypertrophic scars on the abdomen and facial acne scarring in Fitzpatrick skin types I, II, and III; and Keravive, a treatment for scalp health. The company was founded in 1997 and is headquartered in Long Beach, California. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Palantir Stock Soars After Blowout Earnings Report Vertical Aerospace's New Deal and Earnings De-Risk Production Zebra Technologies: Riding the Automation Wave to Profits Stop Overlooking Qualcomm—Here’s What the Market’s Missing Amazon Enters Correction Zone: Time to Panic or Be Brave? Figma's Wild IPO Ride: Is the Stock's Premium Price Justified? Applied Digital: Why a Surge in Bullish Bets Signals a New Era META Gets Huge Upgrades: How High Analysts Think Shares Could Go Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
